NCT00319657View on ClinicalTrials.gov

Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Immune Tolerance
Interventions
BIOLOGICAL

Hematopoietic cell transplantation

Transplantation of hematopoietic stem cells from the living donor.

RADIATION

Total lymphoid irradiation

Total lymphoid irradiation is used as part of the conditioning regimen for the hematopoietic stem cell transplant.

Trial Locations (1)

94305

Stanford University, School of Medicine, Stanford

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Stanford University

OTHER